Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases

BACKGROUND: Preclinical data suggest that sunitinib enhances the efficacy of radiotherapy. We tested the combination of sunitinib and hypofractionated image-guided radiotherapy (IGRT) in a cohort of patients with historically incurable distant metastases. METHODS: Twenty five patients with oligometa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Charles C. L., Ko, Eric C., Sung, Max W., Cesaretti, Jamie A., Stock, Richard G., Packer, Stuart H., Forsythe, Kevin, Genden, Eric M., Schwartz, Myron, Lau, K. H. Vincent, Galsky, Matthew, Ozao-Choy, Junko, Chen, Shu-hsia, Kao, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384658/
https://www.ncbi.nlm.nih.gov/pubmed/22761653
http://dx.doi.org/10.1371/journal.pone.0036979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384658/
https://www.ncbi.nlm.nih.gov/pubmed/22761653
http://dx.doi.org/10.1371/journal.pone.0036979

Ejemplares similares